The IMAGE Group at the University of Colorado Anschutz Medical Campus is no longer recruiting men
(aged 45-85 years) with prostate cancer for this research study (COMIRB # 02-958). The study compared the effectiveness
of weight lifting to help prevent some of the side effects of hormone therapy to reduce testosterone levels. Some recent
studies indicate that exercise might reduce fatigue and may improve longevity and quality of life in men with prostate
This study will involve the following:
- Treadmill stress test (screening for heart disease)
- Ultrasounds of carotid and femoral arteries
- DXA scans (screening for osteoporosis)
- Oral glucose tolerance test (screening for diabetes)
- Weight lifting instruction and training
Participants will be men with prostate cancer who have received hormone therapy (for example, Lupron, Zoladex or
Eligard injections) in the past year. The principal investigator for this study is Wendy Kohrt, Ph.D.
Compensation not provided.
1 Archives of Internal Medicine. 2005 May 9;165(9):1005-10.
2 Journal of Clinical Oncology. 2003 May 1;21(9):1651-2.